当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析 - 资产负债表

国药一致

(000028)

  

流通市值:102.28亿  总市值:119.08亿
流通股本:5.26亿   总股本:6.12亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金5,932,972,054.815,179,155,635.247,802,381,494.25,645,915,765.38
  应收票据及应收账款23,141,044,097.624,286,199,219.5921,933,332,669.4625,203,363,810.76
  其中:应收票据370,193,402.57387,069,825.83395,008,082.75395,986,084.81
        应收账款22,770,850,695.0323,899,129,393.7621,538,324,586.7124,807,377,725.95
  应收款项融资1,181,301,274.611,148,099,434.761,002,830,735.51983,389,852.75
  预付款项305,189,543.88283,901,550.57408,218,855.84282,107,003.04
  其他应收款合计502,530,531.24611,954,880.05591,737,333.31557,913,663.23
  存货8,158,400,560.668,473,670,184.138,121,516,928.618,341,948,399.43
  合同资产2,395,952.832,068,423.572,981,548.96,901,782.2
  其他流动资产264,838,490.86323,298,873.37332,752,975.88146,088,469.82
  流动资产合计39,488,672,506.4940,308,348,201.2840,195,752,541.7141,167,628,746.61
非流动资产:
  长期股权投资3,257,251,769.013,236,445,561.163,166,315,160.283,078,795,255.32
  其他权益工具投资12,420,792.7812,420,792.7812,420,792.789,760,710.7
  其他非流动金融资产89,739,339.1596,797,786.2799,124,870.95121,035,235.31
  投资性房地产80,604,836.1981,474,305.3582,343,037.9683,277,482.58
  固定资产725,340,745.64750,183,608.79784,573,202.85799,355,403.5
  在建工程20,231,029.1917,933,315.1721,662,133.2420,588,421.7
  使用权资产1,739,438,843.71,789,656,568.911,886,036,888.192,094,833,512.66
  无形资产385,229,053.18397,958,716.59406,690,677.91449,101,562.34
  商誉1,604,919,504.761,604,919,504.761,604,919,504.761,858,837,313.13
  长期待摊费用287,741,391.53309,168,199.34335,232,809.88357,858,101.74
  递延所得税资产322,896,784.86322,299,936.92308,722,894.99298,899,053.16
  其他非流动资产156,027,285.33196,169,688.77192,476,463.53218,891,781.93
  非流动资产合计8,681,841,375.328,815,427,984.818,900,518,437.329,391,233,834.07
  资产总计48,170,513,881.8149,123,776,186.0949,096,270,979.0350,558,862,580.68
流动负债:
  短期借款1,828,105,582.182,522,437,530.562,602,187,146.513,538,138,064.18
  应付票据及应付账款20,304,593,882.6620,518,159,013.6120,515,902,140.8321,350,575,362.14
  其中:应付票据8,892,517,662.949,003,920,128.6410,156,529,347.138,500,204,277.68
        应付账款11,412,076,219.7211,514,238,884.9710,359,372,793.712,850,371,084.46
  预收款项18,733,361.8917,943,391.5219,970,057.0820,321,693.44
  合同负债339,137,003.22361,489,559.28367,240,295.88294,068,496.34
  应付职工薪酬225,709,438.47202,911,032.54271,257,980.87254,603,142.6
  应交税费307,742,173.81328,227,196.14324,066,480.06326,016,310.91
  其他应付款合计1,250,735,196.141,194,686,097.981,222,130,452.49817,081,000.2
  其中:应付利息24,760,139.2417,629,685.0925,738,175.1716,061,682.85
        应付股利10,538,824.4610,538,824.4610,538,824.4610,538,824.46
  一年内到期的非流动负债690,731,052.51710,902,999.87740,454,403.44827,828,090.49
  其他流动负债38,015,842.9140,834,762.0141,933,859.4532,777,801.75
  流动负债合计25,003,503,533.7925,897,591,583.5126,105,142,816.6127,461,409,962.05
非流动负债:
  租赁负债833,319,402.02862,199,035.28912,182,012.681,022,413,794.11
  长期应付款6,938,1896,938,1896,938,1896,938,189
  长期应付职工薪酬584,000611,000611,000678,000
  预计负债33,164.4122,839.55311,617.52-
  递延收益66,803,833.7167,711,322.7168,483,353.9265,290,594.6
  递延所得税负债87,555,982.9589,590,882.1693,869,252.66106,028,359.17
  其他非流动负债277,499,053.11286,307,756.39284,248,183.13350,430,039.89
  非流动负债合计1,272,733,625.191,313,481,025.091,366,643,608.911,551,778,976.77
  负债合计26,276,237,158.9827,211,072,608.627,471,786,425.5229,013,188,938.82
所有者权益(或股东权益):
  实收资本(或股本)612,221,584556,565,077556,565,077556,565,077
  资本公积4,267,624,054.834,267,617,637.914,267,617,637.914,267,617,637.91
  其他综合收益-282,458.7-276,281.1-276,281.1-1,485,019.87
  盈余公积278,282,538.5278,282,538.5278,282,538.5278,282,538.5
  未分配利润13,715,477,262.2313,795,236,803.5813,507,774,303.2613,328,965,937.95
  归属于母公司股东权益合计18,873,322,980.8618,897,425,775.8918,609,963,275.5718,429,946,171.49
  少数股东权益3,020,953,741.973,015,277,801.63,014,521,277.943,115,727,470.37
  股东权益合计21,894,276,722.8321,912,703,577.4921,624,484,553.5121,545,673,641.86
  负债和股东权益合计48,170,513,881.8149,123,776,186.0949,096,270,979.0350,558,862,580.68
公告日期2026-08-292026-04-302026-04-022025-10-31
审计意见(境内)标准无保留意见
TOP↑